Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01370850 · ClinicalTrials.gov registry record
Clinical Validation Study of RTVue Features
A clinical trial, sponsored by Optovue.
- Completed
- Registry status
- 53
- Enrollment target
NCT01370850: Completed study, sponsored by Optovue.
NCT01370850 is a clinical trial that has completed, run by Optovue. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01370850 has completed, sponsored by Optovue.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
To perform a clinical validation study of RTVue features in volunteers with various ocular pathology or no ocular pathology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-04 |
What the finished NCT01370850 record still lists
NCT01370850 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01370850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01370850 about?
NCT01370850 is a clinical study titled "Clinical Validation Study of RTVue Features". To perform a clinical validation study of RTVue features in volunteers with various ocular pathology or no ocular pathology.
What is the current status of trial NCT01370850?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2011-03. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT01370850?
This trial is sponsored by Optovue, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia